2/20
08:07 am
amgn
Myris Therapeutics is Developing Ultra-High DAR ADCs to Enable Novel Precision Medicine Treatments for Cancer [Yahoo! Finance]
Low
Report
Myris Therapeutics is Developing Ultra-High DAR ADCs to Enable Novel Precision Medicine Treatments for Cancer [Yahoo! Finance]
2/18
10:28 pm
amgn
Celltrion Expands Biosimilar Portfolio in the European Union Following European Commission Approval of Two Biosimilars [Yahoo! Finance]
Low
Report
Celltrion Expands Biosimilar Portfolio in the European Union Following European Commission Approval of Two Biosimilars [Yahoo! Finance]
2/18
09:07 am
amgn
GeminiBio Appoints Mike Stella to Board [Yahoo! Finance]
Low
Report
GeminiBio Appoints Mike Stella to Board [Yahoo! Finance]
2/18
09:03 am
amgn
FELDAN THERAPEUTICS ACCELERATES GROWTH WITH STRATEGIC INVESTMENT FROM LINEARIS VENTURES [Globe and Mail, The (Toronto, Canada)]
Low
Report
FELDAN THERAPEUTICS ACCELERATES GROWTH WITH STRATEGIC INVESTMENT FROM LINEARIS VENTURES [Globe and Mail, The (Toronto, Canada)]
2/17
04:26 pm
amgn
Improve Your Retirement Income with These 3 Top-Ranked Dividend Stocks [Yahoo! Finance]
Low
Report
Improve Your Retirement Income with These 3 Top-Ranked Dividend Stocks [Yahoo! Finance]
2/17
10:07 am
amgn
Biotech API Manufacturing Services Market to Surpass US$ 73 Bn by 2031 | Driven by Rising Demand for Biologics & Personalized Medicine – Latest Report by TMR [Yahoo! Finance]
Low
Report
Biotech API Manufacturing Services Market to Surpass US$ 73 Bn by 2031 | Driven by Rising Demand for Biologics & Personalized Medicine – Latest Report by TMR [Yahoo! Finance]
2/17
07:56 am
amgn
Amgen Inc. (AMGN): A Bull Case Theory [Yahoo! Finance]
Low
Report
Amgen Inc. (AMGN): A Bull Case Theory [Yahoo! Finance]
2/17
03:12 am
amgn
Anti-Osteoporosis Fracture Healing Market to Reach USD 23,558.5 Million by 2035 at a 4.2% of CAGR, Driven by Aging Population & Innovation [Yahoo! Finance]
Low
Report
Anti-Osteoporosis Fracture Healing Market to Reach USD 23,558.5 Million by 2035 at a 4.2% of CAGR, Driven by Aging Population & Innovation [Yahoo! Finance]
2/14
04:30 pm
amgn
AMGEN TO PRESENT AT CITI'S 2025 VIRTUAL ONCOLOGY LEADERSHIP SUMMIT [Yahoo! Finance]
Low
Report
AMGEN TO PRESENT AT CITI'S 2025 VIRTUAL ONCOLOGY LEADERSHIP SUMMIT [Yahoo! Finance]
2/14
04:01 pm
amgn
AMGEN TO PRESENT AT CITI'S 2025 VIRTUAL ONCOLOGY LEADERSHIP SUMMIT
Low
Report
AMGEN TO PRESENT AT CITI'S 2025 VIRTUAL ONCOLOGY LEADERSHIP SUMMIT
2/12
05:27 am
amgn
$22.68 Bn Adalimumab, Infliximab, Etanercept and Trastuzumab Biosimilars Market Opportunities and Strategies to 2033 [Yahoo! Finance]
Low
Report
$22.68 Bn Adalimumab, Infliximab, Etanercept and Trastuzumab Biosimilars Market Opportunities and Strategies to 2033 [Yahoo! Finance]
2/11
07:38 am
amgn
Navigator Medicines Appoints Tausif ‘Tosh' Butt as Chief Executive Officer and Khurem Farooq as Chairman of the Board of Directors [Yahoo! Finance]
Low
Report
Navigator Medicines Appoints Tausif ‘Tosh' Butt as Chief Executive Officer and Khurem Farooq as Chairman of the Board of Directors [Yahoo! Finance]
2/10
08:00 am
amgn
Amgen Inc. (NASDAQ: AMGN) had its price target raised by analysts at Piper Sandler from $310.00 to $329.00. They now have an "overweight" rating on the stock.
Low
Report
Amgen Inc. (NASDAQ: AMGN) had its price target raised by analysts at Piper Sandler from $310.00 to $329.00. They now have an "overweight" rating on the stock.
2/7
04:01 pm
amgn
AMGEN TO PRESENT AT THE 35th ANNUAL OPPENHEIMER HEALTHCARE LIFE SCIENCES CONFERENCE
Low
Report
AMGEN TO PRESENT AT THE 35th ANNUAL OPPENHEIMER HEALTHCARE LIFE SCIENCES CONFERENCE
2/6
03:13 pm
amgn
Amgen obesity drug on hold; Regeneron sets first dividend [Yahoo! Finance]
Low
Report
Amgen obesity drug on hold; Regeneron sets first dividend [Yahoo! Finance]
2/6
08:13 am
amgn
Amgen Inc. (NASDAQ: AMGN) had its price target raised by analysts at Bank of America Co. from $256.00 to $275.00. They now have an "underperform" rating on the stock.
Medium
Report
Amgen Inc. (NASDAQ: AMGN) had its price target raised by analysts at Bank of America Co. from $256.00 to $275.00. They now have an "underperform" rating on the stock.
2/6
04:49 am
amgn
Amgen (AMGN) Q4 2024 Earnings Call Transcript [Yahoo! Finance]
Medium
Report
Amgen (AMGN) Q4 2024 Earnings Call Transcript [Yahoo! Finance]
2/5
10:24 pm
amgn
AMGN's General Medicine Drugs [Yahoo! Finance]
Medium
Report
AMGN's General Medicine Drugs [Yahoo! Finance]
2/5
01:47 pm
amgn
Why Amgen (AMGN) Stock Is Trading Up Today [Yahoo! Finance]
Low
Report
Why Amgen (AMGN) Stock Is Trading Up Today [Yahoo! Finance]
2/4
09:47 pm
amgn
Amgen Discloses FDA Paused Study of Early-Stage Obesity Drug [Yahoo! Finance]
Medium
Report
Amgen Discloses FDA Paused Study of Early-Stage Obesity Drug [Yahoo! Finance]
2/4
08:52 pm
amgn
Amgen Inc. 2024 Q4 - Results - Earnings Call Presentation [Seeking Alpha]
Medium
Report
Amgen Inc. 2024 Q4 - Results - Earnings Call Presentation [Seeking Alpha]
2/4
08:10 pm
amgn
Amgen Discloses FDA Paused Study of Early-Stage Obesity Drug [Yahoo! Finance Canada]
Medium
Report
Amgen Discloses FDA Paused Study of Early-Stage Obesity Drug [Yahoo! Finance Canada]
2/4
05:16 pm
amgn
Amgen, Enphase Energy, Mondelez: After-Hours Earnings [Yahoo! Finance]
Medium
Report
Amgen, Enphase Energy, Mondelez: After-Hours Earnings [Yahoo! Finance]
2/4
05:06 pm
amgn
Amgen, Enphase Energy, Mondelez: After-Hours Earnings [Yahoo! Finance Canada]
Medium
Report
Amgen, Enphase Energy, Mondelez: After-Hours Earnings [Yahoo! Finance Canada]
2/4
05:02 pm
amgn
Key Takeaways from Amgen's Q4 Results [Yahoo! Finance]
Medium
Report
Key Takeaways from Amgen's Q4 Results [Yahoo! Finance]